Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Ranplan wins order worth USD 2.5 million (SEK 22.5 million)

Cambridge UK, 4 February 2019 – Ranplan Wireless has secured a significant order with an initial value of USD 2.5 million (SEK 22.5 million) for its suite of network planning tools from Marubun Corporation, its reselling partner in Japan, for deployment by an ambitious mobile operator. Revenue is expected to be recognised during 2019.Alastair Williamson, Ranplan Wireless CEO, commented, “We are delighted with this order as it provides a solid platform to accelerate our revenue growth in 2019. The size of this deal demonstrates not only the market opportunity for our software solutions but

Follicum's new topical formulation of FOL-005 results in increased hair growth on a par with leading commercial product

Follicum AB ("Follicum" or "company") today reports results for lead candidate FOL-005 in an in vivo-model for hair growth. The study examined hair growth in test animals after treatment with the new creamlike topical formulation of FOL-005 at three different doses. Applied once a day and after about one week of treatment, growth of new hair was observed. The study shows that treatment with Follicum's newly developed formulation results in good hair growth comparable to that of minoxidil, a leading commercial product. The best effect was seen with the highest dose and a clear dose response

Atea Denmark wins large new frame agreement to the public sector

Staten og Kommunernes Indkøbs Service A/S (SKI), the largest public procurement organization in Denmark, has awarded Atea Denmark a new frame agreement to supply servers, storage and related services, to Danish central, regional and local governments. The frame agreement has an estimated value of more than DKK 700 million over 2 years, with the opportunity to extend for an additional two years. Atea is one of four vendors who have been selected for the new frame agreement. The frame agreement replaces several other agreements that are due to expire, but has also been expanded to cover

We want to build for life and health in Hagastaden

The City of Stockholm is proposing a land allocation agreement to Castellum, regarding three blocks of offices and residences in Hagastaden. Total investment for the acquisition of building rights has been calculated to approx. 800 million Swedish kronor. Construction is scheduled to begin in the first quarter of 2021, with occupancy in 2024, at the earliest.“It feels fantastic to be along on the creation of a totally unique city district with science, life-and-living, and health in focus. We can contribute here with attractive workplaces and designing a life sciences cluster, as well as

Holding(s) in Company

TR-1: Standard form for notification of major holdings NOTIFICATION OFMAJOR HOLDINGS (tobe sent to therelevantissuer and to theFCA in MicrosoftWord format ifpossible)i 1a. Identity of the Faroeissuer or the Petroleumunderlying issuer of plcexisting sharesto which votingrights areattachedii:1b. Please indicateif the issuer isa non-UK issuer (please mark withan "X" ifappropriate)Non-UK issuer2. Reason for thenotification (pleasemark theappropriate box orboxes with an"X")An

Handelsbanken’s year-end report for January-December 2018 will be presented on February 6

Handelsbanken will present its results for January­‑December 2018 in Stockholm on February 6, 2019, at 9:15 a.m. CET, at a meeting with the media and analysts. The year-end report for January‑December 2018 will be published at 7:00 a.m. CET, on February 6, 2019. A telephone conference will be held at 10:30 a.m. CET (4:30 a.m. EST), when Rolf Marquardt, CFO, will present and comment on the results. There will also be time for questions from the participants. UK number: +44 20–3364 5374Swedish number: +46 8–505 564 74US number: +1 855–753 2230 Instructions 1. Dial +xx

First patient treated in Redwood Pharma Phase II study

Redwood Pharma AB (publ) today announces that the first patient has begun testing of RP101 in a Phase II clinical trial. RP101 is an innovative treatment for chronic dry eye disease in postmenopausal women.Redwood Pharma’s Phase II clinical trial is a randomized and vehicle (placebo) -controlled multicenter study that will be conducted at clinics in Austria, Hungary and Germany. Approximately 100 patients will be each evaluated during a 3-month treatment period. Assuming the trial proceeds according to plan, results should be published no later than Q1 2020. The objectives are to show

New Camstar Electronics Suite provides game-changing smart manufacturing capabilities for electronics and mechanical processes

· Single software solution integrates Siemens’ Camstar and Mentor’s Valor manufacturing execution capabilities · Integration with the Siemens smart manufacturing for electronics portfolio expands the digital thread from design through manufacturing · Real-time data acquisition of mechatronics manufacturing processes helps provide continuous quality improvementSiemens announced today the introduction of Camstar™ Electronics Suite software, an innovative manufacturing execution system (MES) for electronics. Building on the successful enterprise-level platform for integrated circuit (IC)

JM signs conditional agreement for the acquisition of property on Stora Essingen in Stockholm

JM has signed a conditional agreement to acquire the properties Ångtvätten 16, Tvålen 7 and Stora Essingen 1:4 following final approval for the local planning. The planned project includes approximately 230 residential units.The properties are located on the north side of the island of Stora Essingen. They include more than 19,000 m2 of rentable space that consists primarily of commercial premises and a parking garage. The planned acquisition is part of a larger development area comprising around 700 residential units. The price will be agreed, and cash will be paid in conjunction with

Svenska Aerogel receives repeat order for Quartzene

Italian Barozzi Vernici S.r.l. has placed a second order to meet demand for thermo insulating plasters based on QuartzeneHeating and cooling of buildings represent 36% of the total CO2 footprint in Europe. The demands from the EU have increased through the new revised Building Directive (EPBD) and the member states will have to establish stronger long-term renovation strategies to lower the CO2 emissions and energy consumption. This will be accomplished by introducing complementary innovative techniques, where thermal insulating plasters and coatings will come to play important roles. “

Fortum's Financial Statements and Operating and Financial Review 2018 published

FORTUM CORPORATION STOCK EXCHANGE RELEASE 4 FEBRUARY 2019 AT 9.00 EET Fortum's Financial Statements, Operating and Financial Review 2018, and the Auditor’s report have been published. In addition, Fortum's Corporate Governance Statement and Remuneration Statement have been published as separate reports. The above mentioned materials are attached to this release and can also be downloaded from the company's web site at www.fortum.com/investors. The other products of Fortum's annual reporting entity, the CEO's Business Review, the Tax Footprint, and the Financials, will be published

Support for renewable jet fuel from Finnish travelers – 80% want to reduce emissions at their source

Neste Corporation Press release, 4 February 2019 at 9 am (EET) Neste has investigated Finnish attitudes to flight-related emissions and their offsetting or compensation. Renewable aviation fuel was the respondents’ preferred method of compensating for or offsetting of flight-related emissions. 80 percent of all respondents considered renewable aviation fuel an interesting or very interesting option, as it has a concrete impact on emissions where they are generated. A study carried out by Neste* revealed that recent public debate of flight-related emissions has had an effect

Share buy-backs in Nordic Waterproofing during week 5, 2019

During the period January 28, 2019, until and including February 1, 2019, Nordic Waterproofing Holding A/S has repurchased in total 14,315 own shares (ISIN: DK0060738409). The share buy-backs form part of the SEK 18 million share buy-back program that Nordic Waterproofing announced on December 20, 2018. The share buy-back program, which runs between December 20, 2018, and March 29, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the “Safe Harbour Regulation”).During the period

Biovica announces that the company's quality system is updated in accordance with  ISO 13485:2016.

Uppsala, Sweden, February 4, 2019. Biovica, develops and commercializes blood-based biomarker assays that improve the monitoring of modern cancer therapies and better predict patient outcome, announced today that the company has certified their Quality System according to the ISO13485:2016 standard for the development, manufacturing and sale of DiviTum® at the yearly surveillance audit with Biovica’s notified body.Biovica has been ISO certified since 2010. The update means that Biovica continues to fulfil the regulatory requirements for the development, manufacturing and sale of the company’

The Nomination Committee’s proposal for new Board members and new Chairman of the Board in Starbreeze

STOCKHOLM, SWEDEN (4 February 2019) – The Nomination Committee in Starbreeze AB (publ) proposes the election of Jan Benjaminson, Torgny Hellström and Kerstin Sundberg as new ordinary members of the Board and that Torgny Hellström is elected new Chairman of the Board.The Company announced in a press release on December 20, 2018, that the ambition was to convene an Extraordinary General Meeting of shareholders (EGM) before the end of the first quarter 2019 in order to elect new Board members. The Company’s Board did no longer hold a quorum as Board members had resigned, which was announced in

Share buy-backs in Telia Company during week 5 2019

During the period January 28, 2019, until February 1, 2019, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 1,733,162 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 20, 2018. The share buy-back programme, which runs between April 23, 2018, and March 22, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

New study to learn from every cancer patient treated with magnetic resonance radiation therapy

The MOMENTUM study is a transformative approach to evaluating innovative medical technologyUTRECHT, The Netherlands, February 4, 2019 – Today, the international MR-linac Consortium announced the launch of the MOMENTUM study. The study is designed to generate data that enable safe, fast and, above all, 'evidence-based' introduction of magnetic resonance radiation therapy (MR/RT) into clinical practice. The MOMENTUM study represents the next step in the development of the Elekta Unity MR/RT system; the study will be focused on building a robust body of real-world clinical evidence and

Fraktio selects Cinode to boost business growth

Cinode is proud to welcome Finnish Fraktio to its community of customers. A partnership in line with Cinode’s focus on the Finnish market."We have a long history making some of the most demanding software products and services on the web. Organising our teams and simultaneously growing our company has been a combination of manual work, planning, and spreadsheets - I kid you not! Cinode is the first product designed according to a software company’s needs. Other products are for different use cases or not suitable for us. Cinode's product vision is aligned with our vision", says Jesse

Targovax ASA: Announcement of fourth quarter and full year results 2018

Oslo, Norway, 4 February 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, will announce its fourth quarter and full year 2018 results on Thursday, 14 February 2019. A presentation by Targovax's management to investors, analysts and the press will take place in Oslo at 10:00 CET.The quarterly report and the presentation will be available at www.targovax.com in the Investors section from 07:30 CET.PresentationThe presentation will take place at 10:00 CET at:Hotel ContinentalStortingsgaten 24/26

AKERBP: Discovery at Froskelår

Aker BP is currently drilling exploration well 24/9-14 on the Froskelår Main prospect. The well has encountered oil and gas. Preliminary analysis indicates a gross discovery size within the previously communicated estimate of 45-153 million barrels oil equivalents. Froskelår Main is located in the Alvheim area and follows the Frosk discovery from last year. The major part of the discovery is in licence 869 on the Norwegian Continental Shelf, while a part may straddle the UK-Norwegian border in the North Sea. The drilling operation will continue, and a comprehensive data collection

New study shows Integrum’s OPRA™ Implant System to be safe and durable method to treat thumb amputees

Integrum, a leading provider of innovative solutions for bone anchored prosthetics, is pleased to announce that the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) has published details of a study featuring Integrum’s OPRA™ implant system to enable osseointegrated thumb reconstruction. The study results, published in the January 2019 issue, indicate that the OPRA™ Implant System is a safe and durable method to treat patients with thumb amputations.The retrospective single center study, based on preoperative and postoperative data collected from 13 thumb amputees, concludes

Invitation to THQ Nordic’s Q4 presentation

THQ Nordic hereby invites you to a presentation in connection with the publishing of the interim report for the fourth quarter of 2018. The report will be published the same morning, well before the market opens.The presentation will be held in English by CEO Lars Wingefors and afterwards you will be invited to ask questions. The event will last approximately one hour. Date: February 13, 2019. Time: 09:00 (CET) Place: Carnegie Hall, Regeringsgatan 56, Stockholm. Please register in advance for physical presence or telephone conference participation: https://financialhearings.

Sympatex kicks-off the 2019/2020 season with four new apparel partners: MAMMUT, ZANIER, ON and LAGOPED

Mammut and Lagoped receive prestigious ISPO awards by integrating innovative products from Sympatex. Austrian market leader Zanier achieves a 60 percent reduction in CO2 with the new Sympatex-based gloves. On introduces a stylish running jacket.Munich / Unterföhring, February 3, 2019 – At the 2019 ISPO, Sympatex is once again proving that consistent sustainability does not require sacrificing style and design, or restricting performance. As a result, the functional textiles specialist is entering the coming season with another four renowned apparel partners in tow, all of who chose climate-

NGEx Closes Last Tranche of C$20 Million Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BRITISH COLUMBIA, February 1, 2019 /CNW/ - NGEx Resources Inc. ("NGEx" or the "Company") (TSX:NGQ)(Nasdaq Stockholm:NGQ), is pleased to report that it has closed the last tranche of its previously announced C$20 million private placement (the “Offering”) and in connection therewith, has issued 666,000 common shares (the “Common Shares”) at a price of C$1.00 per Common Share for gross proceeds of C$666,000. Taking into account the closing of the first tranche of 19,334,000 Common

There are no items matching the current filter
There are no more items matching the current filter
Back to top